Related Experiment Videos

The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease

J Dierkes1, E Bissé, M Nauck

  • 1Institut für Klinische Chemie und Pathobiochemie, Otto-von-Guericke Universität Magdeburg, Germany. jutta.dierkes@medizin.uni-magdeburg.de

Insights

Hyperhomocysteinemia, an elevated homocysteine level, is a significant risk factor for coronary artery disease. This study shows homocysteine is as important as traditional risk factors in identifying patients at high risk.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Chemistry

Background:

  • Hyperhomocysteinemia is a common risk factor for coronary artery disease (CAD).
  • The diagnostic value of homocysteine compared to other risk factors for CAD is not well-established.

Purpose of the Study:

  • To compare the diagnostic value of homocysteine with traditional risk factors for coronary artery disease.
  • To evaluate the utility of receiver-operator characteristic (ROC) analysis for homocysteine in identifying high-risk individuals.

Main Methods:

  • Retrospective case-control study involving 191 CAD patients and 231 healthy controls.
  • Assessment of lifestyle habits via questionnaire.
  • Measurement of laboratory parameters including homocysteine, folate, vitamin B12, lipoproteins, and lipids.
  • Comparison of diagnostic values using ROC analysis.

Main Results:

  • Homocysteine demonstrated significant discrimination between CAD cases and controls.
  • ROC analysis indicated homocysteine is at least as important as conventional risk factors like high-density-lipoprotein cholesterol, triglycerides, and non-esterified fatty acids.
  • Homocysteine showed weak correlations with folate, vitamin B12, age, and serum creatinine.

Conclusions:

  • Hyperhomocysteinemia is a crucial risk factor for coronary artery disease, comparable in importance to established factors.
  • ROC analysis of homocysteine is effective for identifying individuals at highest risk for CAD.
  • Further clinical trials are warranted to investigate homocysteine-lowering therapies, such as vitamin supplementation, for CAD prevention.

Related Concept Videos